Results 11 to 20 of about 7,978,447 (307)

A paradigm shift for cardiovascular outcome evaluation in diabetes: Major adverse cardiovascular events (MACE) to major adverse vascular events (MAVE)

Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2023
Drugs for diabetes are required to demonstrate cardiovascular safety through CV outcome trials (CVOT). The pre-defined end-points for cardiovascular outcome studies may not be sufficient to capture all clinically relevant atherosclerotic cardio vascular disease (ASCVD) events particularly peripheral arterial disease (PAD).We planned a scoping review ...
Ashu Rastogi, Anand Sudhayakumar, Nicolaas C. Schaper, Edward B. Jude   +3 more
openaire   +3 more sources

Impact of acute kidney injury on major adverse cardiovascular events in intensive care survivors [PDF]

BJA Open, 2023
Background: Acute kidney injury commonly occurs in patients admitted to ICU. After acute kidney injury, kidney function may not completely recover leading to increased risk of future cardiovascular events.
Mark Andonovic, Jennifer Curle, Jamie P. Traynor, Martin Shaw, Malcolm A.B. Sim, Patrick B. Mark, Kathryn A. Puxty   +6 more
doaj   +2 more sources

Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIV

JACC: Advances
Background: People with HIV (PWH) are at increased risk for atherosclerotic cardiovascular diseases (ASCVDs) and geriatric syndromes, including frailty.
Kristine M. Erlandson, MD, MS, Ariela R. Orkaby, MD, Triin Umbleja, MSc, Heather J. Ribaudo, PhD, Todd T. Brown, MD, PhD, Markella V. Zanni, MD, Marissa R. Diggs, AB, Sarah M. Chu, MSN, Kathleen V. Fitch, MSN, Carl J. Fichtenbaum, MD, Carlos Malvestutto, MD, MPH, Judith A. Aberg, MD, Gerald S. Bloomfield, MD, MPH, Judith S. Currier, MD, Karen T. Tashima, MD, Marcus Vinícius Guimarães de Lacerda, MD, PhD, Sonya L. Heath, MD, Michael T. Lu, MD, MPH, Alan Landay, PhD, George A. Kuchel, MD, Pamela S. Douglas, MD, Steven K. Grinspoon, MD   +21 more
doaj   +4 more sources

Prediabetes as a risk factor for major adverse cardiovascular events [PDF]

Annals of Medicine, 2021
Type II diabetes mellitus (DM) is a proinflammatory process and a known risk factor for major adverse cardiac events (MACE). The same inflammatory markers may be present in prediabetes (pDM); however, the relationship between pDM by HbA1c and MACE is not well studied.
Ramy Mando, Muhammad Waheed, Adrian Michel, Patrick Karabon, Alexandra Halalau   +4 more
openaire   +3 more sources

Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events [PDF]

JAMA Network Open, 2022
ImportancePatients with stroke due to nontraumatic (spontaneous) intracerebral hemorrhage (ICH) often harbor vascular risk factors and comorbidities, but it is unclear which major adverse cardiovascular events (MACEs) occur more frequently among patients with a prior ICH than the general population.ObjectiveTo evaluate the risk of a MACE for patients ...
Gaist, David, Hald, Stine Munk, García Rodríguez, Luis Alberto, Clausen, Anne, Möller, Sören, Hallas, Jesper, Al-Shahi Salman, Rustam; id_orcid 0000-0002-2108-9222   +6 more
openaire   +4 more sources

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis [PDF]

Cureus, 2020
Introduction Rheumatoid arthritis is a chronic, inflammatory, and multisystem disease, which, along with the joints, can involve the cardiovascular system. The treatment of rheumatoid arthritis or rheumatoid arthritis itself can lead to atherosclerosis, which is considered one of the major causes by which it can affect the cardiovascular system.
Mal, Kheraj, Kumar, Ratan, Mansoor, Farah, Kaur, Navneet, Kumar, Anil, Memon, Sidra, Rizwan, Amber   +6 more
openaire   +2 more sources

Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment

PLOS ONE, 2023
Background Hyperuricemia is common during tuberculosis (TB) treatment, especially in association with pyrazinamide (PZA). This study investigated the relationship between major adverse cardiovascular events (MACEs) and hyperuricemia during TB treatment. Methods We conducted a single-center retrospective cohort study.
Hong-Joon Shin, Joon-Young Yoon, Young-Ok Na, Jae-Kyeong Lee, Bo Gun Kho, Tae-Ok Kim, Yu-Il Kim, Sung-Chul Lim, Sae-Hee Jeong, Yong-Soo Kwon   +9 more
openaire   +4 more sources

Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients [PDF]

Reviews on Recent Clinical Trials, 2018
Psoriatic arthritis is a chronic inflammatory arthropathy that affects 14%- 30% of patients with skin and/or nail psoriasis, leading to severe physical limitations and disability. It has been included in the group of spondyloarthropathy with which it shares clinical, radiologic, and serologic features in addition to familial and genetic relationship ...
Peluso, Rosario, Caso, Francesco, Tasso, Marco, Ambrosino, Pasquale, Nicola, Matteo, Di Minno, Dario, Lupoli, Roberta, Criscuolo, Livio, Caso, Paolo, Ursini, Francesco, Del Puente, Antonio, Scarpa, Raffaele, Costa, Luisa   +12 more
openaire   +4 more sources

Cardiovascular risk in patients with and without diabetes presenting with chronic coronary syndrome in 2004–2016

BMC Cardiovascular Disorders, 2021
Background It was recently shown that new-onset diabetes patients without previous cardiovascular disease have experienced a markedly reduced risk of adverse cardiovascular events from 1996 to 2011. However, it remains unknown if similar improvements are
Esben Skov Jensen, Kevin Kris Warnakula Olesen, Christine Gyldenkerne, Pernille Gro Thrane, Lisette Okkels Jensen, Bent Raungaard, Per Løgstrup Poulsen, Reimar Wernich Thomsen, Michael Maeng   +8 more
doaj   +1 more source

Predicting Major Adverse Cardiovascular Events Following Carotid Endarterectomy Using Machine Learning

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Carotid endarterectomy (CEA) is a major vascular operation for stroke prevention that carries significant perioperative risks; however, outcome prediction tools remain limited.
Ben Li, Raj Verma, Derek Beaton, Hani Tamim, Mohamad A. Hussain, Jamal J. Hoballah, Douglas S. Lee, Duminda N. Wijeysundera, Charles de Mestral, Muhammad Mamdani, Mohammed Al‐Omran   +10 more
doaj   +1 more source